• Citer

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

par Barst, Robyn J.;Mubarak, Kamal K;Machado, Roberto F;Ataga, Kenneth I;Benza, Raymond L.;Castro, Oswaldo;Naeije, Robert ;Sood, Namita;Swerdlow, Paul S;Hildesheim, Mariana;Gladwin, Mark T;ASSET study group,
Référence British journal of haematology, 149, 3, page (426-435)
Publication Publié, 2010-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.
Auteur:	Barst, Robyn J.; Mubarak, Kamal K; Machado, Roberto F; Ataga, Kenneth I; Benza, Raymond L.; Castro, Oswaldo; Naeije, Robert; Sood, Namita; Swerdlow, Paul S; Hildesheim, Mariana; Gladwin, Mark T; ASSET study group,
Informations sur la publication:	British journal of haematology, 149, 3, page (426-435)
Statut de publication:	Publié, 2010-05
Sujet CREF:	Physiologie générale
Mots-clés:	Endothelin receptor antagonism
	Exercise capacity
	Haemodynamics
	Pulmonary hypertension
	Sickle cell anaemia
MeSH keywords:	Vascular Resistance -- drug effects
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	FLWIN
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0007-1048
	info:doi/10.1111/j.1365-2141.2010.08097.x
	info:pii/BJH8097
	info:scp/77950820615
	info:pmid/20175775
	PMC2914575